Graves' Disease: A Long-Term Quality-of-Life Follow Up of Patients Randomized to Treatment with Antithyroid Drugs, Radioiodine, or Surgery

Abraham-Nordling, Mirna, Törring, Ove, Hamberger, Bertil, Lundell, Göran, Tallstedt, Leif, Calissendorff, Jan, Wallin, Göran·2005·Thyroid
DOI 10.1089/thy.2005.15.1279

Cited by (165)

Items 101–165 of 165

  1. Antigen-specific therapy of Graves acute disease and orbitopathy by induction of tolerance
    Martin Ungerer · 2018 · Frontiers in bioscience
  2. Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease
    Xiaodong Liu, Wendy WL Chan, Eric Ho Man Tang, Alex HY Suen, Matrix MH Fung, Yu Cho Woo, Shirley Yuk‐Wah Liu, Cindy Lo Kuen Lam, Nan Luo, Carlos King Ho Wong et al. · 2023 · Health and Quality of Life Outcomes
  3. Unveiling Promising Modalities and Enhancing Patient Outcomes in Graves’ Disease Treatment: A Systematic Review and Meta-Analysis
    Hadeel Rshash Almutairi, Faisal Salem Alqadi, Rama K Alsulaim, Ghada Y AlKhoraiji, Lana Alwasel, Latifh M Alharbi, Layan Alharbi, Samar Alsamiri, Betool R Alqfari, Taif A Almayouf et al. · 2024 · Cureus
  4. In the shadow of Graves’ disease: a qualitative interview study of patients’ experiences conducted at a secondary referral centre in Sweden
    Agneta Lindo, Sara Alsén, Andreas Fors, Helena Filipsson Nyström · 2025 · BMJ Open
  5. Risk Factors and Clinical Manifestations in Hyperthyroidism: Case Report
    Yusrita Anidha, Wilis Cahyaning Ayu, Nur Mufida Wulan Sari, Siti Rahayu Nadhiroh · 2023 · Amerta Nutrition
  6. The need for the GREAT+ score to predict relapse in Graves’ disease: a questionnaire among patients and internal medicine specialists
    Heleen I. Jansen, C. Heuveling van Beek, Peter H L T Bisschop, Annemieke C. Heijboer, Eveline Bruinstroop, Anita Boelen · 2024 · Journal of Endocrinological Investigation
  7. Development and validation of a questionnaire to assess health-related quality-of-life in cats with hyperthyroidism
    Fabienne Blunschi, Imogen Schofield, Sofie Muthmann, Natali Bettina Bauer, Katarina Hazuchova · 2024 · Journal of Veterinary Internal Medicine
  8. British Thyroid Association Survey of Graves' Disease Management in the UK
    Michael Atkinson, Medha Agrawal, Koteshwara Muralidhara, Prakash Abraham, Bijay Vaidya, Onyebuchi E Okosieme · 2025 · Clinical Endocrinology
  9. Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves’ Disease in Ethiopia
    Habtamu Solomon Mengistu, Kidus Tesfaye Getahun, Lake Alemayehu, Sifrash Gezahagn · 2022 · ClinicoEconomics and Outcomes Research
  10. Thyroidectomy versus antithyroid drugs in Graves’ disease: a meta-analysis of randomized controlled trials
    Xiaogang Zheng, Yi Zhu, Ming Gao Chen, Yong Cheng Su, Xiao Ming Wu · 2025 · BMC Surgery
  11. Unveiling Risk Factors for Treatment Failure in Patients with Graves’ Disease: A Nationwide Cohort Study in Korea
    Jung A Kim, Kyeong Jin Kim, Jimi Choi, Kyoung Jin Kim, Eyun Song, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim et al. · 2025 · Endocrinology and Metabolism
  12. Management of Graves’ Hyperthyroidism: More Than a Century of Progression
    Hengameh Abdi, Atieh Amouzegar · 2020 · Intern J Endocrinol Metab
  13. Psychosocial Factors in Patients with Thyroid Disease
    Petra Mandincov · 2012 · InTech eBooks
  14. “Ioning” Out Thyroid Autoimmunity
    Anthony Peter Weetman · 2009 · Endocrine Practice
  15. Clinical efficacy of combined rituximab treatment in a woman with severe Graves' ophthalmopathy
    Xiaomei Liu, Hui Guo, Juan Liu, Bingyin Shi · 2016 · Experimental and Therapeutic Medicine
  16. Reflections on the Management of Graves’ Hyperthyroidism
    Chantal Daumerie, Jacques Orgiazzi · 2018 · European Thyroid Journal
  17. PERSPECTIVE: Prioritizing quality of life in the management of hyperthyroidism: an expert clinical perspective
    Angelos Kyriacou, Nadia Sawicka‐Gutaj, Akheel A. Syed, Petros Perros · 2026 · Endocrine Connections
  18. Hyperthyroidism
    STEPHEN H. LAFRANCHI · 2011 · Elsevier eBooks
  19. Changes in the Ocular Parameters of Patients with Graves’ Disease after Antithyroid Drug Treatment
    Je‐Sang Lee, Dong-Ju Yeom, Seung Kwan Nah, Bo‐Yeon Kim, Sun Young Jang · 2021 · Medicina
  20. Influence of Owner Personality and Other Owner-, Cat- and Treatment-Related Factors on the Perception of Quality of Life in Cats With Hyperthyroidism
    Sofie Muthmann, Imogen Schofield, Martin Kersting, Fabienne Blunschi, Joana Léonie Tiefenbrunner, Natali Bettina Bauer, Katarina Hazuchova · 2025 · Journal of Veterinary Internal Medicine
  21. Treatment Modalities in Thyroid Dysfunction
    Rhodri King, R.A. Ajj · 2012 · InTech eBooks
  22. Secular Trends in Ablation Therapy for Graves’ Disease: An Analysis of a 15-Year Experience at a Tertiary Hospital in South Korea
    Min Joo Kim, Ye An Kim, Sun Wook Cho, Su‐jin Kim, Kyu Eun Lee, Young Joo Park, Do Joon Park, Bo Youn Cho · 2021 · Journal of Clinical Medicine
  23. A Patient With Graves’ Disease And Thyroid-Associated Orbitopathy Undergoing Radioactive Iodine in Dr. Soetomo General Academic Hospital, Surabaya
    Rizki Adrian Hakim, Stepanus Massora, Delfitri Lutfi, Hermina Novida · 2021 · Biomolecular and Health Science Journal
  24. Radioiodine Therapy of Hyperthyroidism in Graves’ Disease
    Wai Yin Wong, Anthony S. W. Goh · 2012 · Medical radiology
  25. Surgical considerations for adult Graves’ disease: a narrative review of indications, perioperative challenges and postoperative outcomes
    Luigi Bartalena, Daniela Gallo, Eliana Piantanida, Maria Laura Tanda · 2026 · Expert Review of Endocrinology & Metabolism
  26. Ultrasound-guided thermal ablation in patients affected by Graves’ disease: a systematic review and meta-analysis
    Elisa Gatta, Riccardo Morandi, Claudio Casella, Roberto Negro, Mario Rotondi, Carlo Cappelli · 2026 · Endocrine
  27. Comparative Efficacy of Radioiodine Therapy With Adjunctive Thionamides vs Either Treatment Alone in the Management of Graves Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Seyed Reza Mirjalili, Elham Razmpoosh, Reza Eshraghi, Marziyeh Ashoori, Sepideh Soltani · 2025 · The Journal of Clinical Endocrinology & Metabolism
  28. Brain fatigue in Graves’ disease: symptoms and presentation of a possible mechanism at the cellular level
    Karin Tammelin, M HOLMBERG, Agneta Lindo, Birgitta Johansson, Lars Rönnbäck, Helena Filipsson Nyström · 2026 · European Thyroid Journal
  29. Patología tiroidea en atención primaria
    Arturo Louro González, Ángel Núñez Vázquez, Fernando Cordido Carballido, Natalia Gómez Gómez, Marta Lois Rodríguez, María Cordido Carro · 2016 · FMC - Formación Médica Continuada en Atención Primaria
  30. Integrative Approaches to Patients Undergoing Thyroid Surgery
    Beatriz R. Olson · 2017 · Springer eBooks
  31. Quality of Life in Graves’ Ophthalmopathy
    Elizabeth A. Bradley, Molly L. Fuller · 2015 · Springer eBooks
  32. Treatment of relapsed hyperthyroidism
    Jae Hoon Chung · 2018 · Journal of Korean Medical Association
  33. Quality of Life Is Worse at 6-10 Years after Radioactive Iodine Treatment of Graves’ Disease as Compared with Antithyroid Drugs or Surgery
    Sun Young Lee · 2019 · Clinical Thyroidology
  34. Graves’ Disease
    Sanjay Saran · 2021 · IntechOpen eBooks
  35. Quality of Life after Thyroid Surgery
    Alessandro Antonelli, Poupak Fallahi · 2012 · Wiley eBooks
  36. Thyroid associated ophthalmopathy : Treatment for hyperhyroidism and evaluation of methods for measuring saccadic eye movements
    Frank Träisk · 2009 · Figshare
  37. Hyperthyroidism : Incidence and long term quality-of-life
    Mirna Abraham‐Nordling · 2008 · Figshare
  38. Fatigue and cognition - hormonal perspectives
    Marika Christina Möller · 2012 · Figshare
  39. Molecular Etiology of Graves’ Disease and Associated Ophthalmopathy
    Tereza Planck · 2010 · Lund University Publications (Lund University)
  40. Reliability, validity, and responsiveness of the short form 36 (SF-36) health survey questionnaire in patients with Graves’ disease
    Jing Yu, Yi‐Yuan Tang · 2013 · Asian Biomedicine
  41. DIFFUSED TOXIC GOITER: A FIVE YEAR EXPERIENCE
    S Aliyu, Abubaker Ibrahim · 2015
  42. Clinical Evidence Concise
    Birte Nygaard · 2012
  43. Thyrotoxicosis: State of the Art Management
    Anthony Peter Weetman · 2014 · The Endocrine Society eBooks
  44. The Role of Surgery for Nodular Hyperthyroidism
    Dawn M. Elfenbein, David F. Schneider · 2017 · Springer eBooks
  45. Evaluation of cardiovascular complexities and quality of life related to health in Chinese patients with thyrotoxic heart disease secondary to toxic diffuse goiter
    Dacheng Yang, Fengjun Liu, Teng Ma · 2018 · Biomedical Research - India
  46. Failure of RAI Therapy in Graves' Disease Is Related to Higher Initial Serum FT 4 and TRAb Levels
    Mary H. Samuels · 2019 · Clinical Thyroidology
  47. Updates of Radioiodine Treatment for Graves' Disease
    Shin Young Jeong · 2019 · International Journal of Thyroidology
  48. Endocrine Surgery
    Christopher D. Raeburn, Jonathan A. Schoen, Robert C. McIntyre · 2009 · Elsevier eBooks
  49. Effetto del radioiodio sulla qualità di vita a lungo termine nei pazienti guariti dal Morbo di Graves-Basedow
    Maria Laura Tanda · 2020 · L Endocrinologo
  50. Antithyroid drug therapy for Graves’ disease
    Soo Myoung Shin, Ka Hee Yi · 2021 · Journal of Korean Medical Association
  51. 18 Surgery for Graves’ Disease and Hyperthyroidism
    2021 · Thieme Medical Publishers eBooks
  52. Graves’ Disease
    Josephine H. Li, Natasha Kasid, James V. Hennessey · 2019 · Springer eBooks
  53. Clinical, sonographical and cytological comparison of toxic and non-toxic thyroid nodules
    Zeynep Çetin, Derya Köseoğlu, Özden Özdemir Başer · 2022 · Journal of Health Sciences and Medicine
  54. Hyperthyroidism and Benign Thyroid Nodules Therapy: Role of Nuclear Medicine
    George Barbério Coura-Filho, Mayara Torres Silva de Oliveira, Ana Luiza Morais de Campos · 2022 · Springer eBooks
  55. Hyperthyreose- und gutartige Schilddrüsenknotentherapie: Rolle der Nuklearmedizin
    George Barbério Coura-Filho, Mayara Torres Silva de Oliveira, Ana Luiza Morais de Campos · 2024 · Springer eBooks
  56. Evaluation of Radioiodine Therapy in the Refractory Hyperthyroidism
    Samira Rahimlou, Sahar Rezaei, Noushin Milanchian, Esmaeil Gharepapagh · 2023 · Bulletin de la Banque Méllié Iran.
  57. An Effective Straightforward Protocol for the Treatment of Graves’ Hyperthyroidism for Primary Care Providers
    Felisha Eugenio, Syed M. Kazim Raza, Ishmum Hasan, Christina P. Moldovan, Mohan Zopey, Mayer B. Davidson, Theodore C. Friedman · 2023 · Current Trends in Internal Medicine
  58. Comparison of the Changes in Quality-of-Life of Cats with Hyperthyroidism Treated with Radioiodine or Antithyroid Drugs—A Preliminary Study
    Fabienne Blunschi, Sofie Muthmann, Natali Bettina Bauer, Katarina Hazuchova · 2025 · Veterinary Sciences
  59. Long-term Management of Graves’ Disease: Balancing Clinical Effectiveness, Safety Considerations, and Patient-focused Treatment
    Shahjada Selim · 2025 · Bangladesh Journal of Endocrinology and Metabolism
  60. Additional file 1 of Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease
    Liu, Xiaodong, Wendy WL Chan, Eric Ho Man Tang, Alex HY Suen, Matrix MH Fung, Woo, Yu Cho, Shirley Yuk‐Wah Liu, Lam, Cindy LK, Luo, Nan, Wong, Carlos KH et al. · 2023 · Figshare
  61. Novel ThyPRO-39-based nomogram for identifying impaired quality of life in Graves’ hyperthyroidism outpatients: development and internal validation
    Juan Nie, Yiqing Wang, Yajing Mo, Chao Liu, Shuhang Xu, Doudou Li · 2026 · Endocrine Connections
  62. Quality of life in refractory Graves’ hyperthyroidism: a cross-sectional study comparing long-term ATDs therapy versus L-T4 replacement after iodine-131
    Anqi Yuan, Zhe Yan, Jialu Wu, Yifei Song, Hui Huang · 2026 · Frontiers in Endocrinology
  63. Effect of Different Therapeutic Approaches on Quality of Life of Patients with Graves’ disease: A Systematic Review and Meta-Analysis Running title: Treatment and Quality of Life in Graves’ Disease
    Shervin Mossavarali, Ali Vaezi, Dorsa Ghorban Sarvi, Niloofar Mirdamadi, Shahrzad Mohseni, Mahnaz Pejman Sani · 2026 · Research Square
  64. Neuropsychiatric manifestations of Graves’ disease with a focus on depression anxiety and psychiatric comorbidities
    Sandli Jain, Bhumi Chaturvedi, Hemant Bareth, Anupama Sharma, Mahaveer Singh, Deepak Nathiya, Balvir Singh Tomar · 2026 · Discover Public Health
  65. Graves' disease (autoimmune hyperthyroidism) and fatigue – understandable, identifiable, and manageable
    Birgitta Johansson, Lars Rönnbäck, Helena Filipsson Nyström · 2026 · Elsevier eBooks